Advertisement
Exelixis, Inc.

Exelixis, Inc. (EXEL) Stock Overview

Explore Exelixis, Inc.โ€™s financial performance, market position, analyst ratings, and future outlook.

EXELโ—NASDAQ
HealthcareBiotechnology
$53.08
$1.34(2.59%)
U.S. Market is Open ยท 11:56
Advertisement

Exelixis, Inc. (EXEL)

Meyka AI Score

Z

Key Financials

Market Cap13.3B
P/E Ratio16.47
EPS (TTM)$3.02
ROE0.40%
Fundamental Analysis

AI Price Forecasts

1 Month$46.75
3 Months$43.61
1 Year Target$55.38

EXEL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Exelixis, Inc. (EXEL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.33, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $55.38.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 16.47 and a market capitalization of 13.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.42%
5-Day Change
1.96%
1-Month Change
10.03%
3-Month Change
25.06%
6-Month Change
26.56%
Year-to-Date (YTD) Change
20.90%
1-Year Change
23.46%
3-Year Change
175.99%
5-Year Change
132.62%
All-Time (Max) Change
259.25%

Contact Information

650 837 7000
1851 Harbor Bay Parkway, Alameda, CA, 94502

Company Facts

1,147 Employees
IPO DateApr 17, 2000
CountryUS
Actively Trading

Frequently Asked Questions